# C_2016347EN.01003701.xml

| 22.9.2016 | EN | Official Journal of the European Union | C 347/37 |
| --- | --- | --- | --- |

22.9.2016

EN

Official Journal of the European Union

C 347/37

---

Prior notification of a concentration

(Case M.8192 — Advent International/THL/inVentiv)

Candidate case for simplified procedure

(Text with EEA relevance)

(2016/C 347/09)

| 1. | On 15 September 2016, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Advent International (US) and Thomas H. Lee Partners (US) acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of part of inVentiv (US) by way of purchase of shares. |
| --- | --- |

1.

On 15 September 2016, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Advent International (US) and Thomas H. Lee Partners (US) acquire within the meaning of Article 3(1)(b) of the Merger Regulation control of part of inVentiv (US) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | Advent International is a private equity investor. It acquires equity stakes (both controlling and non-controlling) in companies in the following sectors: business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecoms. |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

Advent International is a private equity investor. It acquires equity stakes (both controlling and non-controlling) in companies in the following sectors: business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecoms.

| — | THL is a private equity firm that invests in global businesses in the following broad sectors: consumer and healthcare; media and information services; and business and financial services. |
| --- | --- |

—

THL is a private equity firm that invests in global businesses in the following broad sectors: consumer and healthcare; media and information services; and business and financial services.

| — | inVentiv is a global provider of clinical development and commercialisation services. Its main clients are pharmaceutical, biotechnology, generic drug and medical device companies. |
| --- | --- |

—

inVentiv is a global provider of clinical development and commercialisation services. Its main clients are pharmaceutical, biotechnology, generic drug and medical device companies.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in this Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.8192 — Advent International/THL/inVentiv, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.8192 — Advent International/THL/inVentiv, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---